Detailed price information for Algernon Health Inc (AGNPF) from The Globe and Mail including charting and trades.
A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging. Among patients with high-risk nonmetastatic ...
The Sweden-based Phase II trial will evaluate how well the company's gallium-68-labeled PET tracer identifies best responders to Enhertu.